Close Menu

NEW YORK (Genomeweb News) – Vermillion today announced an equity financing of up to $18.9 million.

The company said that investors including Oracle Investment Management, Jack W. Schuler, Birchview Fund, and several Vermillion directors have agreed to purchase in a private placement approximately $10.5 million of unregistered shares of its common stock, and warrants to purchase up to $8.4 million in additional shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.